Molecular evolution in breast cancer

Novelties in melanoma treatment at ASCO 2018

Immunotherapy in SCLC

PROPHECY trial: circulating tumor cell AR-V7 detection in mCRPC receiving abiraterone or enzalutamide

State of art NET treatment in 2018

Cabozatinib vs sunitinib in advanced RCC PROPHECY trial: circulating tumor cell AR-V7 detection in mCRPC receiving abiraterone or enzalutamide

Immunotherapy in colorectal cancer

How do I treat early relapsed follicular lymphoma?

Treating sarcoma in elderly patients

VALENTINO study: panitumumab maintenance therapy in RAS WT metastatic colorectal cancer

Cabozantinib alone or in combination with trastuzumab in breast cancer with brain metastases

ALEX Study: alectinib vs crizotinib in untreated advanced ALK+ NSCLC 23

Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Tepotinib in patients with advanced NSCLC harboring MET exon 14-skipping mutations

KEYNOTE-001 trial: 4-year OS for patients with advanced NSCLC

Update on KEYNOTE-052: first-line pembrolizumab in cisplatin-ineligible advanced urothelial cancer